NCT02191254View on ClinicalTrials.gov

Efficacy and Tolerability of Antistax® in Male and Female Patients Suffering From Chronic Venous Insufficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2004

Conditions
Venous Insufficiency
Interventions
DRUG

Antistax®

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY